2-47373890-G-C

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_002354.3(EPCAM):​c.267G>C​(p.Gln89His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00436 in 1,614,118 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0028 ( 3 hom., cov: 32)
Exomes š‘“: 0.0045 ( 22 hom. )

Consequence

EPCAM
NM_002354.3 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:12

Conservation

PhyloP100: 0.971
Variant links:
Genes affected
EPCAM (HGNC:11529): (epithelial cell adhesion molecule) This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PM1
In a domain Thyroglobulin type-1 (size 72) in uniprot entity EPCAM_HUMAN there are 8 pathogenic changes around while only 1 benign (89%) in NM_002354.3
BP4
Computational evidence support a benign effect (MetaRNN=0.013347268).
BP6
Variant 2-47373890-G-C is Benign according to our data. Variant chr2-47373890-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 127848.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=5, Uncertain_significance=1}. Variant chr2-47373890-G-C is described in Lovd as [Likely_benign]. Variant chr2-47373890-G-C is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00284 (433/152236) while in subpopulation NFE AF= 0.00503 (342/68018). AF 95% confidence interval is 0.00459. There are 3 homozygotes in gnomad4. There are 191 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 Mitochondrial gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPCAMNM_002354.3 linkc.267G>C p.Gln89His missense_variant Exon 3 of 9 ENST00000263735.9 NP_002345.2 P16422

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPCAMENST00000263735.9 linkc.267G>C p.Gln89His missense_variant Exon 3 of 9 1 NM_002354.3 ENSP00000263735.4 P16422

Frequencies

GnomAD3 genomes
AF:
0.00285
AC:
433
AN:
152118
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00138
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000754
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00503
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.00272
AC:
684
AN:
251466
Hom.:
3
AF XY:
0.00284
AC XY:
386
AN XY:
135910
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.00191
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000261
Gnomad FIN exome
AF:
0.00102
Gnomad NFE exome
AF:
0.00469
Gnomad OTH exome
AF:
0.00342
GnomAD4 exome
AF:
0.00452
AC:
6604
AN:
1461882
Hom.:
22
Cov.:
33
AF XY:
0.00440
AC XY:
3198
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.000568
Gnomad4 AMR exome
AF:
0.00215
Gnomad4 ASJ exome
AF:
0.00172
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000220
Gnomad4 FIN exome
AF:
0.00118
Gnomad4 NFE exome
AF:
0.00555
Gnomad4 OTH exome
AF:
0.00308
GnomAD4 genome
AF:
0.00284
AC:
433
AN:
152236
Hom.:
3
Cov.:
32
AF XY:
0.00257
AC XY:
191
AN XY:
74418
show subpopulations
Gnomad4 AFR
AF:
0.00130
Gnomad4 AMR
AF:
0.00138
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.000754
Gnomad4 NFE
AF:
0.00503
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00403
Hom.:
3
Bravo
AF:
0.00292
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00581
AC:
50
ExAC
AF:
0.00258
AC:
313
Asia WGS
AF:
0.000289
AC:
2
AN:
3478
EpiCase
AF:
0.00409
EpiControl
AF:
0.00462

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:12
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:6
Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

EPCAM: BP4, BS1, BS2 -

Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 31, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: The EPCAM c.267G>C (p.Gln89His) variant causes a missense change involving a non-conserved nucleotide with 2/3 in silico tools (SNPs&GO and Mutation Taster not captured here due to low reliability index and p-value, respectively) predicting a "damaging" outcome. The variant has been observed in the large, broad control population, ExAC, with an allele frequency of 313/121362 (1/387, 2 homozygotes), which significantly exceeds the estimated maximal expected allele frequency for a pathogenic EPCAM variant of 1/35211, suggesting this variant is likely a benign polymorphism. Multiple clinical diagnostic laboratories cite the variant as "likely benign/benign." Therefore, the variant of interest has been classified as Benign. -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not specified Benign:2
Dec 24, 2013
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 28, 2021
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:2
Jan 28, 2021
Sema4, Sema4
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: curation

- -

Nov 15, 2017
True Health Diagnostics
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Lynch syndrome Benign:1
Mar 11, 2015
CSER _CC_NCGL, University of Washington
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: research

- -

EPCAM-related disorder Benign:1
May 31, 2024
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.022
T;T;.
Eigen
Benign
0.15
Eigen_PC
Benign
0.063
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.33
.;T;T
M_CAP
Benign
0.058
D
MetaRNN
Benign
0.013
T;T;T
MetaSVM
Benign
-0.60
T
MutationAssessor
Uncertain
2.1
.;M;.
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-2.1
N;N;N
REVEL
Benign
0.25
Sift
Uncertain
0.016
D;D;D
Sift4G
Uncertain
0.026
D;D;D
Polyphen
1.0
D;P;.
Vest4
0.37
MutPred
0.49
Gain of helix (P = 0.0164);.;.;
MVP
0.66
MPC
0.078
ClinPred
0.036
T
GERP RS
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.31
gMVP
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs146480420; hg19: chr2-47601029; COSMIC: COSV104560651; COSMIC: COSV104560651; API